Eupraxia Pharmaceuticals will showcase data from its RESOLVE trial at the upcoming ISDE World Congress for Esophageal Diseases in Edinburgh. The presentation will highlight the company’s innovative DiffuSphereTM technology, designed to improve drug delivery for a variety of conditions.